Want to see JP:4524 full AI Analyst Report?

Morishita Jintan Co., Ltd. (4524) Price & Analysis

2 Followers

4524 Stock Chart & Stats

¥2187.00

¥4.00(0.19%)

At close: Jan 08 4:00 PM EST

¥2187.00

¥4.00(0.19%)

Day’s Range― - ―

52-Week Range¥2,100.00 - ¥2,390.00

Previous CloseN/A

Volume1.20K

Average Volume (3M)1.12K

Market Cap

¥9.15B

Enterprise Value¥9.06K

Total Cash (Recent Filing)¥1.52B

Total Debt (Recent Filing)¥1.75B

Price to Earnings (P/E)11.6

Beta0.34

Next Earnings

Nov 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield2.9%

Share Statistics

EPS (TTM)192.52

Shares Outstanding4,150,000

10 Day Avg. Volume860

30 Day Avg. Volume1,120

Financial Highlights & Ratios

PEG Ratio0.99

Price to Book (P/B)0.70

Price to Sales (P/S)0.72

P/FCF Ratio506.33

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and a large equity cushion reduce solvency risk and give the company room to fund product development or absorb volatility. The 2026 debt increase bears monitoring, but current capitalization supports resilience over the next several quarters.

Historical Revenue ExpansionMulti-year revenue growth indicates established demand for the company’s healthcare products, while resilient gross profit suggests its product portfolio retains reasonable pricing and scale benefits despite the latest annual setback.

Improved Operating Cash FlowThe strong operating cash-flow rebound shows that the core business can generate meaningful cash internally. If sustained, this would improve funding capacity for operations and investment without relying heavily on additional borrowing.

Bears Say

Recent Revenue ContractionThe latest top-line decline signals a pause in demand or market expansion and creates a weaker starting point for near-term growth. Sustained contraction could reduce operating leverage and limit the company’s ability to improve profitability.

Volatile Free Cash FlowInconsistent free cash flow indicates that reported earnings do not reliably convert into discretionary funds after investment needs. This limits financial flexibility and could constrain shareholder returns or strategic investment during weaker periods.

Moderate ProfitabilityModerate earnings on the current revenue base suggest limited margin depth and a smaller buffer against input costs, competition, or weaker demand. This may make sustained earnings growth more dependent on renewed sales expansion.

4524 FAQ

What was Morishita Jintan Co., Ltd.’s price range in the past 12 months?

Morishita Jintan Co., Ltd. lowest stock price was ¥2100.00 and its highest was ¥2390.00 in the past 12 months.

What is Morishita Jintan Co., Ltd.’s market cap?

Morishita Jintan Co., Ltd.’s market cap is ¥9.15B.

When is Morishita Jintan Co., Ltd.’s upcoming earnings report date?

Morishita Jintan Co., Ltd.’s upcoming earnings report date is Nov 11, 2026 which is in 56 days.

How were Morishita Jintan Co., Ltd.’s earnings last quarter?

Morishita Jintan Co., Ltd. released its earnings results on Aug 06, 2026. The company reported ¥79.24 earnings per share for the quarter.

Is Morishita Jintan Co., Ltd. overvalued?

According to Wall Street analysts Morishita Jintan Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Morishita Jintan Co., Ltd. pay dividends?

Morishita Jintan Co., Ltd. pays a Annually dividend of ¥65 which represents an annual dividend yield of 2.9%. See more information on Morishita Jintan Co., Ltd. dividends here

What is Morishita Jintan Co., Ltd.’s EPS estimate?

Morishita Jintan Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Morishita Jintan Co., Ltd. have?

Morishita Jintan Co., Ltd. has 4,150,000 shares outstanding.

What happened to Morishita Jintan Co., Ltd.’s price movement after its last earnings report?

Morishita Jintan Co., Ltd. reported an EPS of ¥79.24 in its last earnings report. Following the earnings report the stock price went down -0.272%.

Which hedge fund is a major shareholder of Morishita Jintan Co., Ltd.?

Currently, no hedge funds are holding shares in JP:4524

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Morishita Jintan Co., Ltd.

Morishita Jintan Co., Ltd. is a Japanese enterprise that manufactures and distributes a diverse array of products, encompassing pharmaceuticals, quasi-pharmaceuticals, medical devices, and food items. The company's operations are divided into two main segments: Healthcare Business and Capsule Business. The Healthcare Business division is responsible for the production and sale of its proprietary Jintan branded goods, and also provides original equipment manufacturing (OEM) services for dietary supplements, cosmetic products, and various food items. Concurrently, the Capsule Business division handles both original equipment and design manufacturing (OEM/ODM) for pharmaceutical and food sectors, in addition to innovating and developing capsules for industrial applications. Established in 1893, the company's headquarters are located in Osaka, Japan.